Digital Prescription: Dr Oliver Dorigo on Ovarian Cancer

You may be feeling fear of ovarian cancer after a diagnosis. We hope SurvivorNet can help you deal with your emotions and focus on the journey ahead.

Dr. Oliver Dorigo, an oncologist at Stanford Medical School, explains some of the new testing methods that can guide ovarian cancer treatment.

Understanding Atezolizumab

Olaparib is currently being tested in a clinical trial, the SOLO1 trial, as a front-line therapy for the prevention of recurrence in ovarian cancer.

The drug Bevacizumab, or Avastin, can be an effective treatment for various stages of ovarian cancer, particularly for high-risk cases.

PARP inhibitors are a relatively new class of drugs used in the maintenance phase for ovarian cancer patients. They work by blocking DNA repair.

There are three types of PARP inhibitors: Niraparib, Olaparib, Rucaparib. They have very similar efficacies, but each drug has different side effects.

Ovarian cancer platinum sensitivity. Women with ovarian cancer can develop resistance to platinum-based chemo drugs. Discover more insights.

PARP inhibitors are effective following initial surgery and chemotherapy for ovarian cancer patients, especially for patients with a BRCA mutation.

There are three types of PARP inhibitors. Ultimately, which PARP inhibitor is best will come down to a discussion with your physician.